KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Short-term Investments (2016 - 2025)

Merck (MRK) has disclosed Short-term Investments for 16 consecutive years, with $45.0 million as the latest value for Q3 2025.

  • Quarterly Short-term Investments changed N/A to $45.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $45.0 million through Sep 2025, changed N/A year-over-year, with the annual reading at $447.0 million for FY2024, 77.38% up from the prior year.
  • Short-term Investments for Q3 2025 was $45.0 million at Merck, down from $615.0 million in the prior quarter.
  • The five-year high for Short-term Investments was $718.0 million in Q2 2023, with the low at $40.0 million in Q1 2024.
  • Average Short-term Investments over 4 years is $360.0 million, with a median of $409.5 million recorded in 2022.
  • The sharpest move saw Short-term Investments crashed 94.12% in 2024, then soared 1397.5% in 2025.
  • Over 4 years, Short-term Investments stood at $498.0 million in 2022, then tumbled by 49.4% to $252.0 million in 2023, then soared by 77.38% to $447.0 million in 2024, then crashed by 89.93% to $45.0 million in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $45.0 million, $615.0 million, and $599.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.